FDAnews
www.fdanews.com/articles/124176-spectrum-enters-co-development-commercialization-agreement

Spectrum Enters Co-Development, Commercialization Agreement

February 2, 2010
Spectrum Pharmaceuticals Inc. announced that it has entered into a co-development and commercialization agreement with TopoTarget A/S for Belinostat, a histone deacetylase inhibitor.
RTTNews